https://stock.noler.com/us/stock/callisto-pharmaceuticals-inc https://stock.noler.com/us/stock/callisto-pharmaceuticals-inc/accounts-payable https://stock.noler.com/us/stock/callisto-pharmaceuticals-inc/accretion-amortization-of-discounts-and-premiums-investments https://stock.noler.com/us/stock/callisto-pharmaceuticals-inc/accrued-liabilities-current https://stock.noler.com/us/stock/callisto-pharmaceuticals-inc/activist-13d-13g-form-sc-13d https://stock.noler.com/us/stock/callisto-pharmaceuticals-inc/activist-13d-13g-form-sc-13g https://stock.noler.com/us/stock/callisto-pharmaceuticals-inc/additional-paid-in-capital https://stock.noler.com/us/stock/callisto-pharmaceuticals-inc/adjustments-to-reconcile-net-income-loss-to-cash-provided-by-used-in-operating-activities https://stock.noler.com/us/stock/callisto-pharmaceuticals-inc/allocated-share-based-compensation-expense https://stock.noler.com/us/stock/callisto-pharmaceuticals-inc/amended-reports-10-k https://stock.noler.com/us/stock/callisto-pharmaceuticals-inc/amended-reports-10-q https://stock.noler.com/us/stock/callisto-pharmaceuticals-inc/basic-shares https://stock.noler.com/us/stock/callisto-pharmaceuticals-inc/buybacks-shares-repurchased-value https://stock.noler.com/us/stock/callisto-pharmaceuticals-inc/buybacks-stock-repurchased-value https://stock.noler.com/us/stock/callisto-pharmaceuticals-inc/capital-expenditures https://stock.noler.com/us/stock/callisto-pharmaceuticals-inc/cash-and-equivalents https://stock.noler.com/us/stock/callisto-pharmaceuticals-inc/cash-flow-breakdown https://stock.noler.com/us/stock/callisto-pharmaceuticals-inc/common-stock-par-or-stated-value-per-share https://stock.noler.com/us/stock/callisto-pharmaceuticals-inc/common-stock-value https://stock.noler.com/us/stock/callisto-pharmaceuticals-inc/cover-page-shares-outstanding https://stock.noler.com/us/stock/callisto-pharmaceuticals-inc/current-assets https://stock.noler.com/us/stock/callisto-pharmaceuticals-inc/current-liabilities https://stock.noler.com/us/stock/callisto-pharmaceuticals-inc/debt-interest-rate-stated-percentage https://stock.noler.com/us/stock/callisto-pharmaceuticals-inc/deconsolidation-gain-or-loss-amount https://stock.noler.com/us/stock/callisto-pharmaceuticals-inc/depreciation-and-amortization https://stock.noler.com/us/stock/callisto-pharmaceuticals-inc/derivative-liabilities-noncurrent https://stock.noler.com/us/stock/callisto-pharmaceuticals-inc/diluted-shares https://stock.noler.com/us/stock/callisto-pharmaceuticals-inc/due-to-related-parties-noncurrent https://stock.noler.com/us/stock/callisto-pharmaceuticals-inc/earnings-per-share-basic-and-diluted https://stock.noler.com/us/stock/callisto-pharmaceuticals-inc/eps https://stock.noler.com/us/stock/callisto-pharmaceuticals-inc/eps-basic https://stock.noler.com/us/stock/callisto-pharmaceuticals-inc/equity-method-investments https://stock.noler.com/us/stock/callisto-pharmaceuticals-inc/extinguishment-of-debt-amount https://stock.noler.com/us/stock/callisto-pharmaceuticals-inc/financing-cash-flow https://stock.noler.com/us/stock/callisto-pharmaceuticals-inc/gain-loss-on-sale-of-property-plant-equipment https://stock.noler.com/us/stock/callisto-pharmaceuticals-inc/gains-losses-on-extinguishment-of-debt https://stock.noler.com/us/stock/callisto-pharmaceuticals-inc/general-and-administrative-expense https://stock.noler.com/us/stock/callisto-pharmaceuticals-inc/income-loss-from-equity-method-investments https://stock.noler.com/us/stock/callisto-pharmaceuticals-inc/income-taxes-paid https://stock.noler.com/us/stock/callisto-pharmaceuticals-inc/increase-decrease-in-accounts-payable-and-accrued-liabilities https://stock.noler.com/us/stock/callisto-pharmaceuticals-inc/increase-decrease-in-due-to-related-parties https://stock.noler.com/us/stock/callisto-pharmaceuticals-inc/increase-decrease-in-prepaid-expense https://stock.noler.com/us/stock/callisto-pharmaceuticals-inc/increase-decrease-in-security-deposits https://stock.noler.com/us/stock/callisto-pharmaceuticals-inc/insider-transactions-preferred https://stock.noler.com/us/stock/callisto-pharmaceuticals-inc/insider-transactions-preferred/purchases https://stock.noler.com/us/stock/callisto-pharmaceuticals-inc/insider-transactions-stock-options https://stock.noler.com/us/stock/callisto-pharmaceuticals-inc/insider-transactions-warrants https://stock.noler.com/us/stock/callisto-pharmaceuticals-inc/insider-transactions-warrants/purchases https://stock.noler.com/us/stock/callisto-pharmaceuticals-inc/interest-and-debt-expense https://stock.noler.com/us/stock/callisto-pharmaceuticals-inc/interest-expense-on-debt https://stock.noler.com/us/stock/callisto-pharmaceuticals-inc/investing-cash-flow https://stock.noler.com/us/stock/callisto-pharmaceuticals-inc/investment-income-net https://stock.noler.com/us/stock/callisto-pharmaceuticals-inc/late-filing-notices-nt-10-k https://stock.noler.com/us/stock/callisto-pharmaceuticals-inc/late-filing-notices-nt-10-q https://stock.noler.com/us/stock/callisto-pharmaceuticals-inc/minority-interest https://stock.noler.com/us/stock/callisto-pharmaceuticals-inc/minority-interest-decrease-from-redemptions https://stock.noler.com/us/stock/callisto-pharmaceuticals-inc/net-cash-from https://stock.noler.com/us/stock/callisto-pharmaceuticals-inc/net-cash-from-financing-activities https://stock.noler.com/us/stock/callisto-pharmaceuticals-inc/net-cash-from-investing-activities https://stock.noler.com/us/stock/callisto-pharmaceuticals-inc/net-cash-from-operating-activities https://stock.noler.com/us/stock/callisto-pharmaceuticals-inc/net-change-in-cash https://stock.noler.com/us/stock/callisto-pharmaceuticals-inc/net-income https://stock.noler.com/us/stock/callisto-pharmaceuticals-inc/net-income-loss-attributable-to-noncontrolling-interest https://stock.noler.com/us/stock/callisto-pharmaceuticals-inc/net-income-loss-available-to-common-stockholders-basic https://stock.noler.com/us/stock/callisto-pharmaceuticals-inc/new-accounting-pronouncement-or-change-in-accounting-principle-cumulative-effect-of-change-on-equity-or-net-assets https://stock.noler.com/us/stock/callisto-pharmaceuticals-inc/new-accounting-pronouncement-or-change-in-accounting-principle-effect-of-change-on-net-income https://stock.noler.com/us/stock/callisto-pharmaceuticals-inc/noncash-or-part-noncash-acquisition-net-nonmonetary-assets-acquired-liabilities-assumed https://stock.noler.com/us/stock/callisto-pharmaceuticals-inc/operating-cash-flow https://stock.noler.com/us/stock/callisto-pharmaceuticals-inc/operating-income https://stock.noler.com/us/stock/callisto-pharmaceuticals-inc/other-nonoperating-income https://stock.noler.com/us/stock/callisto-pharmaceuticals-inc/other-nonoperating-income-expense https://stock.noler.com/us/stock/callisto-pharmaceuticals-inc/paid-in-capital-other https://stock.noler.com/us/stock/callisto-pharmaceuticals-inc/paid-in-capital-reallocation-of-minority-interest https://stock.noler.com/us/stock/callisto-pharmaceuticals-inc/paid-in-capital-shares-issued-issuance-costs https://stock.noler.com/us/stock/callisto-pharmaceuticals-inc/paid-in-capital-stock-compensation https://stock.noler.com/us/stock/callisto-pharmaceuticals-inc/paid-in-capital-warrant-issued https://stock.noler.com/us/stock/callisto-pharmaceuticals-inc/payments-of-stock-issuance-costs https://stock.noler.com/us/stock/callisto-pharmaceuticals-inc/payments-to-acquire-short-term-investments https://stock.noler.com/us/stock/callisto-pharmaceuticals-inc/preferred-shares-facts https://stock.noler.com/us/stock/callisto-pharmaceuticals-inc/preferred-stock-accretion-of-redemption-discount https://stock.noler.com/us/stock/callisto-pharmaceuticals-inc/prepaid-expense-and-other-assets-current https://stock.noler.com/us/stock/callisto-pharmaceuticals-inc/proceeds-from-issuance-of-debt https://stock.noler.com/us/stock/callisto-pharmaceuticals-inc/proceeds-from-issuance-or-sale-of-equity https://stock.noler.com/us/stock/callisto-pharmaceuticals-inc/proceeds-from-notes-payable https://stock.noler.com/us/stock/callisto-pharmaceuticals-inc/proceeds-from-sale-maturity-and-collection-of-shortterm-investments https://stock.noler.com/us/stock/callisto-pharmaceuticals-inc/proceeds-from-stock-options-exercised https://stock.noler.com/us/stock/callisto-pharmaceuticals-inc/proceeds-from-warrant-exercises https://stock.noler.com/us/stock/callisto-pharmaceuticals-inc/profit-loss https://stock.noler.com/us/stock/callisto-pharmaceuticals-inc/property-plant-equipment https://stock.noler.com/us/stock/callisto-pharmaceuticals-inc/public-float https://stock.noler.com/us/stock/callisto-pharmaceuticals-inc/research-and-development-expense-excluding-acquired-in-process-cost https://stock.noler.com/us/stock/callisto-pharmaceuticals-inc/research-and-development-in-process https://stock.noler.com/us/stock/callisto-pharmaceuticals-inc/retained-earnings https://stock.noler.com/us/stock/callisto-pharmaceuticals-inc/revenue-from-grants https://stock.noler.com/us/stock/callisto-pharmaceuticals-inc/sec-comment-letters-corresp https://stock.noler.com/us/stock/callisto-pharmaceuticals-inc/sec-comment-letters-upload https://stock.noler.com/us/stock/callisto-pharmaceuticals-inc/sec-filings-10-k https://stock.noler.com/us/stock/callisto-pharmaceuticals-inc/sec-filings-10-q https://stock.noler.com/us/stock/callisto-pharmaceuticals-inc/sec-filings-10ksb https://stock.noler.com/us/stock/callisto-pharmaceuticals-inc/sec-filings-10qsb https://stock.noler.com/us/stock/callisto-pharmaceuticals-inc/sec-filings-15-12b https://stock.noler.com/us/stock/callisto-pharmaceuticals-inc/sec-filings-25-nse https://stock.noler.com/us/stock/callisto-pharmaceuticals-inc/sec-filings-425 https://stock.noler.com/us/stock/callisto-pharmaceuticals-inc/sec-filings-8-a12b https://stock.noler.com/us/stock/callisto-pharmaceuticals-inc/sec-filings-8-k https://stock.noler.com/us/stock/callisto-pharmaceuticals-inc/sec-filings-certamx https://stock.noler.com/us/stock/callisto-pharmaceuticals-inc/sec-filings-def-14a https://stock.noler.com/us/stock/callisto-pharmaceuticals-inc/sec-filings-defa14a https://stock.noler.com/us/stock/callisto-pharmaceuticals-inc/sec-filings-defm14a https://stock.noler.com/us/stock/callisto-pharmaceuticals-inc/sec-filings-pre-14a https://stock.noler.com/us/stock/callisto-pharmaceuticals-inc/sec-filings-prer14a https://stock.noler.com/us/stock/callisto-pharmaceuticals-inc/sec-filings-regdex https://stock.noler.com/us/stock/callisto-pharmaceuticals-inc/sec-filings-sb-2 https://stock.noler.com/us/stock/callisto-pharmaceuticals-inc/sec-filings-sc-14f1 https://stock.noler.com/us/stock/callisto-pharmaceuticals-inc/secondary-offerings-form-424b3 https://stock.noler.com/us/stock/callisto-pharmaceuticals-inc/secondary-offerings-form-effect https://stock.noler.com/us/stock/callisto-pharmaceuticals-inc/secondary-offerings-form-pos-am https://stock.noler.com/us/stock/callisto-pharmaceuticals-inc/secondary-offerings-form-s-3 https://stock.noler.com/us/stock/callisto-pharmaceuticals-inc/secondary-offerings-form-s-8 https://stock.noler.com/us/stock/callisto-pharmaceuticals-inc/secondary-offerings-form-s-8-pos https://stock.noler.com/us/stock/callisto-pharmaceuticals-inc/security-deposit https://stock.noler.com/us/stock/callisto-pharmaceuticals-inc/shareholders-equity https://stock.noler.com/us/stock/callisto-pharmaceuticals-inc/shares-authorized https://stock.noler.com/us/stock/callisto-pharmaceuticals-inc/shares-issued https://stock.noler.com/us/stock/callisto-pharmaceuticals-inc/stock-based-compensation https://stock.noler.com/us/stock/callisto-pharmaceuticals-inc/stock-issued-new-shares-sold https://stock.noler.com/us/stock/callisto-pharmaceuticals-inc/stock-issued-shares-issued-value-issued-for-services https://stock.noler.com/us/stock/callisto-pharmaceuticals-inc/stock-issued-shares-issued-value-other https://stock.noler.com/us/stock/callisto-pharmaceuticals-inc/stock-issued-shares-issued-value-purchase-of-assets https://stock.noler.com/us/stock/callisto-pharmaceuticals-inc/stock-issued-value-of-shares-issued-for-stock-awards https://stock.noler.com/us/stock/callisto-pharmaceuticals-inc/stockholders-equity-including-portion-attributable-to-noncontrolling-interest https://stock.noler.com/us/stock/callisto-pharmaceuticals-inc/taxes-other https://stock.noler.com/us/stock/callisto-pharmaceuticals-inc/total-assets https://stock.noler.com/us/stock/callisto-pharmaceuticals-inc/total-liabilities https://stock.noler.com/us/stock/callisto-pharmaceuticals-inc/total-liabilities-and-equity https://stock.noler.com/us/stock/callisto-pharmaceuticals-inc/unrealized-gain-loss-on-derivatives https://stock.noler.com/us/stock/callisto-pharmaceuticals-inc/weighted-average-number-of-share-outstanding-basic-and-diluted